Cannabis use is one of the most effective treatments effective migraine attacks
Many people confuse migraine headaches with cervicogenic headaches that arise from problems originating in the structures of the neck. Migraine headaches are usually unilateral (affecting one half of the head) and pulsating, lasting from 4 to 72 hours with symptoms of nausea, vomiting, and sensitivity to light. It was once thought that migraines were initiated exclusively by problems with the blood vessels within the brain. However, the root causes of migraines are still unclear and there is new research that suggests they could be caused by CECD (see clinical endocannabinoid deficiency). Cannabis use is one of the most effective treatments for chronic, debilitating migraine attacks. Sufferers report that cannabis buds administered with a vaporizer give sustained relief within a very short period.
Multiple Sclerosis and THC
MS is an autoimmune disease that affects the brain and spinal cord (central nervous system). In medical trials, it was found that although THC does not halt the progress of multiple sclerosis, it does help to ease symptoms dramatically. Studies show that a dosage of 5 milligrams per day of THC produced relief from symptoms. According to clinical trial data published in the Journal of Neurology, Neurosurgery, and Psychiatry, “The oral administration of cannabis extracts significantly reduces muscle stiffness in patients with MS.”
Cannabis helps relieve peripheral muscular pain
An antispasmodic is a drug that suppresses muscle spasms seen in neurologic conditions such as cerebral palsy, multiple sclerosis, and spinal cord disease. Trials show that cannabis helps relieve peripheral muscular pain and cramping as effectively as pharmaceutical medications such as baclofen, tizanidine, and dantrolene, with no side effects. Clinical trials conducted by Jody Corey-Bloom, MD, Ph.D., of the University of California San Diego have shown smoking cannabis cuts spasticity and pain that is resistant to conventional therapy in multiple sclerosis (MS). Spasticity scores on the modified Ashworth scale dropped by an average
2.74 points more with smoked cannabis than with placebo. A difference of 2 or more points is considered clinically meaningful on the 30-point Ashworth scale indicating mobility of elbows, hips, and knees. The trial included 30 patients with treatment-resistant spasticity randomized to double-blind use of a placebo cigarette or smoked cannabis, once daily for
3 days with crossover after an 11-day washout period. Pain scores, although relatively low to begin with at an average of 12 or 13 points on the 100-point Visual Analogue Scale, fell by an additional 5.28 points with cannabis use. (Corey-Bloom J, et al – Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial).